LIPAGLYN - The novel drug for treating Diabetic Dyslipidemia

We understand and respect that your privacy is important to you.

We use and share personal information that you provide online only in ways that we tell you about.

We secure personal information that you provide online to prevent it from being used and shared for other purposes.

For more details, please read our Internet Privacy Policy Statement below or contact us.

Cadila Healthcare Limited*, also known as Zydus, offers online resources designed to provide health, medical, and product-related information and services, as well as corporate and financial news and employment information. In addition, some of our Web sites enable qualified professionals to place orders for our pharmaceutical products, to apply for grants, or to contribute to clinical studies.

Respect for the privacy of personal information about you is very important to us. Zydus Web sites that display this privacy policy statement (“policy”) are committed to collecting, maintaining, and securing personal information about you in accordance with this policy, as well as applicable laws, rules and regulations. This policy applies to personal information (as defined below) collected from Zydus online resources and communications (such as Web sites, e-mail, and other online and downloadable tools) that display a link to this policy. This policy does not apply to personal information collected from offline resources and communications, except in cases where such personal information is consolidated with personal information collected by Zydus online. This policy also does not apply to third-party online resources to which Zydus’s Web sites may link, where Zydus does not control the content or the privacy practices of such resources.